Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
MRK has been in the news recently: Moderna and Merck & Co. reported that a personalized mRNA vaccine reduced melanoma recurrence or death by about 50% at five years. Phase 3 results for the vaccine are expected this year.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.